对偶发性偏头痛的综合预防治疗:随机临床试验的系统审查
María-Karina Vélez-Jiménez1, Adriana Patricia Martínez-Mayorga2,3, Ildefonso Rodriguez-Leyva2,3
1Migraine and Headache Clinic, Hospital Angeles Lomas, Mexico City, Mexico.
Frontiers in neurology
|September 3, 2025
概括
新的偏头痛治疗方法,如CGRP向治疗和gepants有效减少每月偏头痛的几天. 组合疗法可能会带来更大的益处,但会增加副作用,而非药物疗法则可以作为有用的辅助.
科学领域:
- 神经学
- 药理学
- 基于证据的医学
背景情况:
- 偶发性偏头痛是一种常见的致残神经疾病,影响生活质量和工作效率.
- 预防性治疗旨在减少偏头痛的频率,强度和相关残疾.
- 预防策略的有效性和安全性数据比较有限,特别是在低收入和中等收入国家.
研究的目的:
- 系统地审查和对随机对照试验 (RCT) 进行元分析,评估情节性偏头痛的药物和非药物预防治疗方法.
- 评估不同治疗方式的相对有效性和安全性.
主要方法:
- 根据PRISMA指南,在多个数据库中进行了全面的文献搜索.
- 包括在内的RCT比较了成年人患有偶发性偏头痛的预防性治疗与安慰剂或活性比较剂.
- 主要结局包括每月偏头痛日 (MMD),每月头痛日 (MHD),急性药物治疗日 (AMD) 和不良事件 (AEs) 的变化.
主要成果:
- 分析了39个涉及超过15000名患者的RCT.
- 抗CGRP单克隆抗体和虫剂显示出MMD的持续降低,耐受性良好.
- 传统药物具有较高AE率的适度疗效;组合疗法改善了MMD但增加了副作用.
- 非药物干预表明有希望,但缺乏标准化;整体全方位治疗显著减少了MMD与安慰剂 (-1.25天).
结论:
- 针对CGRP的疗法和gepants是有效的第一线预防偏头痛的选择.
- 组合疗法可以提高疗效,但损害耐受性;非药物治疗是有价值的辅助方法.
- 建议采用个性化多模式策略,特别是在资源有限的环境中,考虑到潜在的偏见和试验限制.
相关概念视频
01:11Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
01:30Electroconvulsive Therapy
2.6K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.6K